Opisthorchiasis Treatment Market: How Is Cholangiocarcinoma Risk Driving Preventive Treatment Demand?
Cancer prevention-driven opisthorchiasis treatment — the recognition that O. viverrini infection causes cholangiocarcinoma (CCA) with 5,000 annual deaths in Thailand and poor prognosis creating the treatment-as-prevention market dynamic — generates the most commercially compelling therapeutic rationale, with the Opisthorchiasis Treatment Market reflecting CCA prevention as the...
0 Σχόλια 0 Μοιράστηκε 42 Views 0 Προεπισκόπηση